Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular triamcinolone acetate injection for hip osteoarthritis
NL-OMON39512Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hip osteoarthritis comparing Intramuscular triamcinolone acetate with Placebo saline injection (2 arms). Primary endpoints: Pain severity at 2 weeks and WOMAC pain subscale at 2 weeks. Started Oct 2011; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NL-OMON39512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39512.